4
Changes in Ownership
Vor Biopharma Inc. Filed Acc 0001209191-22-053463
Options or other derivatives
- Chief Medical Officer acquired 364,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Attar Eyal C. Chief Medical Officer | 2022-10-11 | Grant or award · Employee Stock Option (right to buy) | +364,000 | 364,000 | D | ||
Loading xslF345X03/doc4.xml…